4.6 Letter

A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients

Journal

JOURNAL OF GENERAL INTERNAL MEDICINE
Volume 35, Issue 7, Pages 2205-2206

Publisher

SPRINGER
DOI: 10.1007/s11606-020-05822-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD

Liang-Jie Tang, Gang Li, Mohammed Eslam, Pei-Wu Zhu, Sui-Dan Chen, Howard Ho-Wai Leung, Ou-Yang Huang, Grace Lai-Hung Wong, Yu-Jie Zhou, Morten Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Hai-Yang Yuan, Christopher D. Byrne, Giovanni Targher, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng

Summary: This study developed a novel sequential algorithm based on PRO-C3 to identify liver inflammation and fibrosis in MAFLD patients. The algorithm performed well in high-risk patients and can be used to screen high-risk MAFLD patients for clinical trials and emerging pharmacotherapies.

HEPATOLOGY INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D. D. Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Rohit Loomba, Ming-Hua Zheng, Yan Ni

Summary: This study found that in patients with NAFLD, dysregulated bile acid metabolism was associated with liver fibrosis. Serum levels of secondary bile acids were increased in patients with mild fibrosis, along with other clinical and biochemical abnormalities. Combining serum bile acids with clinical/biochemical biomarkers showed good accuracy in identifying mild fibrosis, but performed less well in identifying significant fibrosis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Biochemistry & Molecular Biology

Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice

Danfeng Lin, Qiyan Sun, Zhaoyang Liu, Jiaxuan Pan, Jing Zhu, Shangwen Wang, Sining Jia, Minghua Zheng, Xiaokun Li, Fanghua Gong

Summary: Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, inflammation, fibrosis, and gut dysbiosis. The study found that fibroblast growth factor 21 (FGF21) has a positive effect on treating NAFLD by modulating gut microbiota and bile acid metabolism. Fecal microbiota composition and bile acid profiles were analyzed in NAFLD patients and healthy participants. In NAFLD mice, FGF21 reduced liver damage and restored intestinal structure, accompanied by changes in gut microbiota composition and regulation of dysbiosis in bile acid metabolism. Antibiotic treatment and fecal microbiota transplantation further confirmed the benefits of FGF21. The findings suggest that targeting gut microbiota-regulated bile acid metabolism may be a potential therapeutic approach for improving NAFLD.

FREE RADICAL BIOLOGY AND MEDICINE (2023)

Article Gastroenterology & Hepatology

Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis

Feng Gao, De-Chan Lu, Tian-Lei Zheng, Shi Geng, Jun-Cheng Sha, Ou-Yang Huang, Liang-Jie Tang, Pei-Wu Zhu, Yang-Yang Li, Li-Li Chen, Giovanni Targher, Christopher D. Byrne, Zu-Fang Huang, Ming-Hua Zheng

Summary: This study developed a rapid and practical tool for non-invasive identification of NASH by using SERS spectra and neural network approaches, which outperformed existing serum markers in distinguishing NASH.

HEPATOLOGY INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores

Arun J. Sanyal, Julie Foucquier, Zobair M. Younossi, Stephen A. Harrison, Philip N. Newsome, Wah-Kheong Chan, Yusuf Yilmaz, Victor De Ledinghen, Charlotte Costentin, Ming-Hua Zheng, Vincent Wai-Sun Wong, Magdy Elkhashab, Ryan S. Huss, Robert P. Myers, Marine Roux, Aymeric Labourdette, Marie Destro, Celine Fournier-Poizat, Veronique Miette, Laurent Sandrin, Jerome Boursier

Summary: This study aims to develop and validate two new scoring systems (Agile 4 and Agile 3+) to accurately identify cirrhosis or advanced fibrosis among individuals with non-alcoholic fatty liver disease (NAFLD) attending liver clinics. The results showed that these two novel non-invasive scores outperformed existing scoring systems in identifying cirrhosis or advanced fibrosis and reduced the need for liver biopsy.

JOURNAL OF HEPATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study

Tae Kyung Yoo, Mi Yeon Lee, Seong Hwan Kim, Ming-Hua Zheng, Giovanni Targher, Christopher D. Byrne, Ki-Chul Sung

Summary: A cohort study suggests that metabolic dysfunction-associated fatty liver disease (MAFLD) predicts cardiovascular disease (CVD) mortality better than non-alcoholic fatty liver disease (NAFLD).

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Review Gastroenterology & Hepatology

Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions

Yang-Yang Li, Tian-Lei Zheng, Shu-Yuan Xiao, Peng Wang, Wen-Jun Yang, Li-Lin Jiang, Li-Li Chen, Jun-Cheng Sha, Yi Jin, Sui-Dan Chen, Christopher D. Byrne, Giovanni Targher, Jian-Min Li, Ming-Hua Zheng

Summary: Hepatocytic ballooning is a crucial histological feature in the diagnosis of non-alcoholic steatohepatitis (NASH) and poses diagnostic challenges, as it can be mistaken for cellular edema and microvesicular steatosis. Inter-observer variability exists in assessing the presence and severity of hepatocytic ballooning. This review discusses the underlying mechanisms, such as endoplasmic reticulum stress, unfolded protein response, intermediate filament cytoskeleton rearrangement, appearance of Mallory-Denk bodies, and activation of the sonic Hedgehog pathway, and explores the use of artificial intelligence for detection and interpretation of hepatocytic ballooning.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages

Gong Feng, Xiaoxun Zhang, Liangjun Zhang, Wen-Yue Liu, Shi Geng, Hai-Yang Yuan, Jun-Cheng Sha, Xiao-Dong Wang, Dan-Qin Sun, Giovanni D. Targher, Christopher Byrne, Tian-Lei Zheng, Feng Ye, Ming-Hua Zheng, Jin Chai

Summary: Protein panels in urine can be used to diagnose non-alcoholic fatty liver disease (NAFLD) and determine fibrosis stages. Diagnostic models constructed from urine samples showed good accuracy in identifying NAFLD and its fibrosis stages, which were validated in an independent cohort.

LIVER INTERNATIONAL (2023)

Article Endocrinology & Metabolism

Consensus Statement on the definition and classification of metabolic hyperferritinaemia

Luca Valenti, Elena Corradini, Leon A. Adams, Elmar Aigner, Saleh Alqahtani, Marco Arrese, Edouard Bardou-Jacquet, Elisabetta Bugianesi, Jose-Manuel Fernandez-Real, Domenico Girelli, Hannes Hagstrom, Benjamin Henninger, Kris Kowdley, Guido Ligabue, Donald McClain, Fabrice Laine, Koji Miyanishi, Martina U. Muckenthaler, Alessia Pagani, Patrizia Pedrotti, Antonello Pietrangelo, Daniele Prati, John D. Ryan, Laura Silvestri, C. Wendy Spearman, Per Stal, Emmanuel A. Tsochatzis, Francesca Vinchi, Ming-Hua Zheng, Heinz Zoller

Summary: Hyperferritinaemia is often associated with metabolic dysfunction and fatty liver and is linked to an increased risk of cardiometabolic and liver diseases. The main determinants of ferritin levels in individuals with metabolic dysfunction are genetic variants that affect iron metabolism. However, there is currently a lack of validated criteria for the diagnosis and staging of metabolic hyperferritinaemia, and the benefits of iron depletion therapy remain unclear. In this article, the authors provide an overview of the relationship between hyperferritinaemia and iron accumulation in individuals with metabolic dysfunction and propose updated definitions and staging systems, highlighting research gaps and suggesting future study designs and outcome measures.

NATURE REVIEWS ENDOCRINOLOGY (2023)

Article Multidisciplinary Sciences

Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis

Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Minghua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N. Assis, Shi-Ying Cai, James L. Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai

Summary: The numbers of DUOX2(+)ACE2(+) small cholangiocytes are inversely associated with disease severity in PBC. They may be the target of pIgR-mediated humoral responses. Protecting these cells and targeting anti-pIgR autoantibodies could be valuable strategies for therapeutic interventions in PBC.

NATURE COMMUNICATIONS (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease-Authors' reply

Feng Gao, Christopher D. Byrne, Giovanni Targher, Shuangmu Zhuo, Ming-Hua Zheng, CHESS MAFLD Consortium

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

AutoFibroNet: A deep learning and multi-photon microscopy-derived automated network for liver fibrosis quantification in MAFLD

Huiling Zhan, Siyu Chen, Feng Gao, Guangxing Wang, Sui-Dan Chen, Gangqin Xi, Hai-Yang Yuan, Xiaolu Li, Wen-Yue D. Liu, Christopher D. Byrne, Giovanni Targher, Miao-Yang Chen, Yong-Feng Yang, Jun Chen, Zhiwen Fan, Xitai Sun, Guorong Cai, Ming-Hua Zheng, Shuangmu Zhuo

Summary: This study developed an automated quantitative tool, AutoFibroNet, using multi-photon microscopy and deep learning techniques to accurately stage liver fibrosis in MAFLD patients. AutoFibroNet showed good discrimination in both the training and validation cohorts.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Development and validation of nonalcoholic fatty liver disease test: a simple sensitive and specific marker for early diagnosis of nonalcoholic fatty liver disease

Mohamed Omran, Mona Omr, Amal A. Mohamed, Reem A. Abdelghafour, Nashwa M. Muharram, Mohamed B. Hassan, Abobakrelsedik Fangry, Tarek Emran, Juan P. Arab, Jorge Arnold, Luis Antonio Diaz, Ming-Hua Zheng, Mohamed El-Kassas

Summary: The aim of this study was to develop a noninvasive test for identifying patients with NAFLD based on clinical and routine laboratory data. Elevated CRP, cholesterol, BMI, and ALT levels were significantly associated with NAFLD. The developed NAFLD test showed high diagnostic performance with an AUC of 0.92 and was validated in patients from Egypt, China, and Chile.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease

Gong Feng, Luca Valenti, Vincent Wai-Sun Wong, Yasser Mahrous Fouad, Yusuf Yilmaz, Won Kim, Giada Sebastiani, Zobair M. Younossi, Virginia Hernandez-Gea, Ming-Hua Zheng

Summary: This article discusses the importance of recompensation in the field of cirrhosis, particularly in NAFLD-related cirrhosis. It provides an up-to-date perspective on the natural history of NAFLD, emphasizing its reversible nature, and discusses the mechanisms and challenges of recompensation, as well as outlining future research directions.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Surgery

Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis

Jia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, Ye Xin Koh, Wan-Guang Zhang, Ming-Hua Zheng, Si Xie, Rong-Rui Huo, Chao-Jing Chen, Liang Ma, Jian-Hong Zhong

Summary: Patients with NAFLD-related HCC have similar perioperative complications and mortality compared to those with HCC of other aetiologies. They may also have higher overall and recurrence-free survival.

BJS OPEN (2023)

No Data Available